Autres langues RVL Pharmaceuticals plc

Actions

RVLPQ

IE00BF2HDL56

Recherche biotechnologique et médicale

Marché Fermé - OTC Markets 16:58:37 28/08/2026			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	0,00%		0,00%	-

01/05	Rvl Pharmaceuticals lance Upneeq Reveal Under Eye Complex	CI
08/05/24	Relief Therapeutics réorganise entièrement sa direction	AW

Autres langues

01/05	Rvl Pharmaceuticals Launches Upneeq Reveal Under Eye Complex
04/11/24	RVL Pharmaceuticals plc (OTCPK:RVLP.Q) cancelled the acquisition of acquire Assets of Avenova Brand and Business of NovaBay Pharmaceuticals, Inc..
29/10/24	RVL Pharmaceuticals plc (OTCPK:RVLP.Q) offered to acquire Assets of Avenova Brand and Business of NovaBay Pharmaceuticals, Inc. from NovaBay Pharmaceuticals, Inc. for $11.5 million.
20/05/24	RVL Pharmaceuticals - Upneeq Wins 2024 Shape Skin Award, 'Best for Lift', in the Professional Treatment Category
25/10/23	RVL Pharmaceuticals plc(NasdaqGS:RVLP) dropped from S&P TMI Index
20/10/23	RVL Pharmaceuticals plc(NasdaqGS:RVLP) dropped from NASDAQ Composite Index
12/10/23	Health Care Down as Risk Aversion Hurts Biotech -- Health Care Roundup
12/10/23	Top Midday Decliners
12/10/23	RVL Pharmaceuticals Subsidiaries File for Prepackaged Chapter 11 Change of Control to Lenders
12/10/23	RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
29/09/23	Wall Street Set to Open Higher; Personal Consumption Inflation Data Lower Than Expected
29/09/23	Top Premarket Gainers
22/09/23	RVL Pharmaceuticals plc Announces Resignation of Joaquin Benes and Juan Vergez from the Board of Directors
25/08/23	RVL Pharmaceuticals : Regulation FD Disclosure - Form 8-K
23/08/23	RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference
16/08/23	Top Midday Decliners
16/08/23	RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
14/08/23	Earnings Flash (RVLP) RVL PHARMACEUTICALS Posts Q2 Revenue $8.3M, vs. Street Est of $10.3M
14/08/23	RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review
14/08/23	RVL Pharmaceuticals plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
14/08/23	RVL Pharmaceuticals Provides Update on Strategic Business Review
02/08/23	RVL Pharmaceuticals plc Announces Resignation of Directors
02/08/23	RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
05/07/23	RCL Pharmaceuticals Considers Certain Strategic Alternatives
05/07/23	RVL Pharmaceuticals' Board Authorizes Talks for Aquisition of a Counterparty in an All-Stock Deal